Leo Cancer Care, a Horley, UK-based firm growing medical units, raised an undisclosed quantity in Sequence C funding.
Backers included McLaren Well being Care Company, Cone Well being, Wisconsin Alumni Analysis Basis, Macmillan Most cancers Assist and Aviko Radiopharmaceuticals.
The corporate intends to make use of the funds to increase into the Asian markets, notably in Singapore, Japan, and South Korea, the place they’ve begun constructing groups and establishing a industrial presence.
Led by CEO Stephen Towe, Leo Most cancers Care is a radiation remedy firm offering a household of merchandise that may present a streamlined and environment friendly therapy whereas making the affected person really feel in management. The upright affected person positioning and CT imaging system, named Marie®, makes use of a set radiation beam with sufferers rotated slowly and easily to totally different beam angles as therapy is run. Marie® removes the necessity for a gantry whereas nonetheless offering 360 levels of beam angles. This gantry-less method permits a major discount in spatial footprint and price, notably for proton remedy and carbon ion remedy. The answer permits sufferers to stay in an upright place throughout therapy.
Commenting on the information, Stephen Towe mentioned: “This funding marks an necessary milestone, as it’s going to allow the expansion of our enterprise and permit us to construct the required infrastructure to assist our system as soon as it’s put in at varied websites. The funding may also assist us to construct a worldwide footprint.”
FinSMEs
13/06/2024
